Literature DB >> 19174397

Vascular endothelial growth factor Trap-Eye for diabetic macular oedema.

Peter K Kaiser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19174397     DOI: 10.1136/bjo.2008.144071

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  3 in total

1.  The management of diabetic macular oedema.

Authors:  Adam H Ross; C Clare Bailey
Journal:  Saudi J Ophthalmol       Date:  2011-01-31

Review 2.  Vascular endothelial growth factor trap-eye (Aflibercept) for the management of diabetic macular edema.

Authors:  Ahmadreza Moradi; Yasir Jamal Sepah; Mohammad Ali Sadiq; Humzah Nasir; Salima Kherani; Raafay Sophie; Diana V Do; Quan Dong Nguyen
Journal:  World J Diabetes       Date:  2013-12-15

Review 3.  The clinical utility of aflibercept for diabetic macular edema.

Authors:  Michael W Stewart
Journal:  Diabetes Metab Syndr Obes       Date:  2015-09-18       Impact factor: 3.168

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.